1.
Cigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review and meta-analysis of prospective cohort studies
by Huxley, Rachel R, Dr
The Lancet (British edition), 2011, Vol.378 (9799), p.1297-1305
2.
Diabetes as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 64 cohorts, including 775 385 individuals and 12 539 strokes
by Peters, Sanne A E, PhD
The Lancet (British edition), 2014, Vol.383 (9933), p.1973-1980
3.
Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis
by Xie, Xinfang, MD
The Lancet (British edition), 2016, Vol.387 (10017), p.435-443
4.
Diabetes as risk factor for incident coronary heart disease in women compared with men: a systematic review and meta-analysis of 64 cohorts including 858,507 individuals and 28,203...
by Peters, Sanne A. E
Diabetologia, 2014-05-25, Vol.57 (8), p.1542-1551
5.
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis
by Fox, Caroline S, MD
The Lancet (British edition), 2012, Vol.380 (9854), p.1662-1673
6.
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis
by Mahmoodi, Bakhtawar K, MD
The Lancet (British edition), 2012, Vol.380 (9854), p.1649-1661
7.
Diabetes as a risk factor for heart failure in women and men: a systematic review and meta-analysis of 47 cohorts including 12 million individuals
by Ohkuma, Toshiaki
Diabetologia, 2019-07-18, Vol.62 (9), p.1550-1560
8.
Sex differences in the association between diabetes and cancer: a systematic review and meta-analysis of 121 cohorts including 20 million individuals and one million events
by Ohkuma, Toshiaki
Diabetologia, 2018-07-20, Vol.61 (10), p.2140-2154
9.
Indices of abdominal obesity are better discriminators of cardiovascular risk factors than BMI: a meta-analysis
by Lee, Crystal Man Ying
Journal of clinical epidemiology, 2008, Vol.61 (7), p.646-653
10.
Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial
by Fayad, Zahi A, Prof
The Lancet (British edition), 2011, Vol.378 (9802), p.1547-1559
11.
Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC)
by Woodward, Mark
Heart (British Cardiac Society), 2007-02, Vol.93 (2), p.172-176
12.
Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes
by Zoungas, Sophia
Diabetologia, 2014-09-17, Vol.57 (12), p.2465-2474
13.
Risk prediction models: II. External validation, model updating, and impact assessment
by Moons, Karel G M
Heart (British Cardiac Society), 2012-05, Vol.98 (9), p.691-698
14.
Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio)marker
by Moons, Karel G M
Heart (British Cardiac Society), 2012-05, Vol.98 (9), p.683-690
15.
Body-mass index and cancer mortality in the Asia-Pacific Cohort Studies Collaboration: pooled analyses of 424 519 participants
by Parr, Christine L, Dr
The lancet oncology, 2010, Vol.11 (8), p.741-752
16.
Socioeconomic disadvantage and disease-specific mortality in Asia: systematic review with meta-analysis of population-based cohort studies
by Vathesatogkit, Prin
Journal of epidemiology and community health (1979), 2014-04, Vol.68 (4), p.375-383
17.
The molecular biology of pelvi-ureteric junction obstruction
by Jackson, Laura
Pediatric nephrology (Berlin, West), 2017-03-13, Vol.33 (4), p.553-571
18.
Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial
by Welsh, Paul
Diabetologia, 2018-05-04, Vol.61 (7), p.1581-1591
19.
The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON study
by Oshima, Megumi
Diabetologia, 2019-07-13, Vol.62 (11), p.1988-1997
20.
Glucosamine and chondroitin for knee osteoarthritis: a double-blind randomised placebo-controlled clinical trial evaluating single and combination regimens
by Fransen, Marlene
Annals of the rheumatic diseases, 2015-05, Vol.74 (5), p.851-858
